Neural overexpression of multidrug resistance-associated protein 1 and refractory epilepsy: a meta-analysis of nine studies

被引:14
作者
Sun, Yuqiang [1 ]
Luo, Xiaodong [1 ]
Yang, Kang [1 ]
Sun, Xu [1 ]
Li, Xinyu [1 ]
Zhang, Ce [2 ]
Ma, Shuo [1 ]
Liu, Yaoling [1 ]
Yin, Jian [1 ,3 ]
机构
[1] Dalian Med Univ, Affiliated Hosp 2, Dept Neurosurg, Dalian 116023, Liaoning, Peoples R China
[2] Dalian Med Univ, Affiliated Hosp 2, Dept Pharm, Dalian 116023, Liaoning, Peoples R China
[3] Dalian Med Univ, Affiliated Hosp 2, Epilept Ctr Liaoning, Dalian 116023, Liaoning, Peoples R China
关键词
intractable epilepsy; MRP1; meta-analysis; BRAIN-BARRIER PENETRATION; P-GLYCOPROTEIN; CELLULAR-DISTRIBUTION; EXTRACELLULAR LEVELS; ANTIEPILEPTIC DRUGS; EXPRESSION; TRANSPORTERS; CARBAMAZEPINE; MRP2;
D O I
10.3109/00207454.2015.1015724
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Objective: Overexpression of adenosine triphosphate-binding cassette (ATP-binding cassette (ABC)) transporters may contribute to intractable epilepsy (IE) by reducing brain accumulation of antiepileptic drugs (AEDs). We conducted a meta-analysis of studies on expression and cellular distribution of multidrug resistance-associated protein 1 (MRP1) in IE patients to evaluate the contribution of this protein to AED resistance. In addition, we summarize experiments examining MRP1 expression and substrates in animal models of IE. Methods: The literature search based on pre-established inclusion and exclusion criteria, as well as quality assessment, data extraction and statistical analyses were conducted concurrently by two independent researchers. We identified nine high-quality studies (Jadad score 3) published between 2000 and 2014 on the expression and cellular distribution of MRP1 in IE patients. A fixed effect model was used to calculate pooled odds ratios (ORs) and corresponding 95% confidence intervals (95% CIs). Forest and funnel plots were constructed to assess study heterogeneity and publication bias, respectively. Results: MRP1 expression was significantly higher in both astrocytes (OR = 17.04, 95% CI: 7.69-37.76, P < 0.00001) and neurons (OR = 22.13, 95% CI: 8.52-57.46, P < 0.00001) of IE patients compared to controls, while there was no significant difference in endothelial cell MRP1 expression (OR: 1.47, 95% CI: 0.09-1.79, P = 0.48). Funnel plot symmetry indicated no substantial publication bias. Most relevant preclinical studies from 2000 to 2014 found higher MRP1 expression in IE model rodents. Furthermore, MRP1 overexpression reduced the extracellular concentration of AEDs in brain, while MRP1 inhibitors enhanced brain AED concentrations. Conclusion: Pooled results strongly suggest that MRP1 is overexpressed in both neurons and astrocytes of IE patients. Inhibition of MRP1 may enhance AED efficacy by increasing local drug availability.
引用
收藏
页码:308 / 317
页数:10
相关论文
共 39 条
  • [1] Expression and cellular distribution of multidrug resistance-related proteins in patients with focal cortical dysplasia
    Ak, Hatil
    Ay, Bahadir
    Tanriverdi, Taner
    Sanus, Galip Zihni
    Is, Merih
    Sar, Mehmet
    Oz, Buge
    Ozkara, Cigdem
    Ozyurt, Emin
    Uzan, Mustafa
    [J]. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2007, 16 (06): : 493 - 503
  • [2] Expression and cellular distribution of multidrug resistance-related proteins in the hippocampus of patients with mesial temporal lobe epilepsy
    Aronica, E
    Gorter, JA
    Ramkema, M
    Redeker, S
    Özbas-Gerçeker, F
    van Vliet, EA
    Scheffer, GL
    Scheper, RJ
    van der Valk, P
    Baayen, JC
    Troost, D
    [J]. EPILEPSIA, 2004, 45 (05) : 441 - 451
  • [3] Expression and cellular distribution of multidrug transporter proteins in two major causes of medically intractable epilepsy: Focal cortical dysplasia and glioneuronal tumors
    Aronica, E
    Gorter, JA
    Jansen, GH
    Van Veelen, CWM
    Van Rijen, PC
    Leenstra, S
    Ramkema, M
    Scheffer, GL
    Scheper, RJ
    Troost, D
    [J]. NEUROSCIENCE, 2003, 118 (02) : 417 - 429
  • [4] Valproic acid is not a substrate for P-glycoprotein or multidrug resistance proteins 1 and 2 in a number of in vitro and in vivo transport assays
    Baltes, Steffen
    Fedrowitz, Maren
    Tortos, Carlos Luna
    Potschka, Heidrun
    Loescher, Wolfgang
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2007, 320 (01) : 331 - 343
  • [5] Multidrug resistance proteins expression in glioma patients with epilepsy
    Calatozzolo, Chiara
    Pollo, Bianca
    Botturi, Andrea
    Dinapoli, Loredana
    Carosi, Mariantonia
    Salmaggi, Andrea
    Maschio, Marta
    [J]. JOURNAL OF NEURO-ONCOLOGY, 2012, 110 (01) : 129 - 135
  • [6] Chen Y. J., 2006, THESIS
  • [7] Chen YH, 2005, NERV DIS MENT HLTH, V5, P411
  • [8] Multidrug resistance-associated protein 1 decreases the concentrations of antiepileptic drugs in cortical extracellular fluid in amygdale kindling rats
    Chen, Ying-hui
    Wang, Cui-cui
    Xiao, Xia
    Wei, Li
    Xu, Guoxiong
    [J]. ACTA PHARMACOLOGICA SINICA, 2013, 34 (04) : 473 - 479
  • [9] Multidrug resistance-associated proteins: Expression and function in the central nervous system
    Dallas, Shannon
    Miller, David S.
    Bendayan, Reina
    [J]. PHARMACOLOGICAL REVIEWS, 2006, 58 (02) : 140 - 161
  • [10] Modulation of drug transporters at the blood-brain barrier
    Fricker, G
    Miller, DS
    [J]. PHARMACOLOGY, 2004, 70 (04) : 169 - 176